Krystal Biotech, Inc. (KRYS)

Krystal Biotech Stock Forecast

Stock Price Forecast

According to 9 professional analysts, the 12-month price target for Krystal Biotech stock ranges from a low of $176 to a high of $255. The average analyst price target of $214.22 forecasts a -8.50% decrease in the stock price over the next year.

Price Target: $214.22 (-8.50%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$176	$214.22	$215	$255
Change	-24.83%	-8.50%	-8.17%	+8.91%

* Price targets were last updated on Nov 4, 2025.

Analyst Ratings

The average analyst rating for Krystal Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	7	7	6	6	6	6
Buy	2	1	1	1	1	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	10	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yigal Nochomovitz Citigroup	Citigroup	Hold Maintains $166 → $198	Hold	Maintains	$166 → $198	-15.43%	Nov 4, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $216 → $220	Strong Buy	Maintains	$216 → $220	-6.04%	Nov 4, 2025
Alec Stranahan B of A Securities	B of A Securities	Strong Buy Maintains $182 → $255	Strong Buy	Maintains	$182 → $255	+8.91%	Oct 17, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $240	Strong Buy	Reiterates	$240	+2.51%	Sep 15, 2025
Geulah Livshits Chardan Capital	Chardan Capital	Strong Buy Maintains $219 → $216	Strong Buy	Maintains	$219 → $216	-7.74%	Aug 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

395.50M

Increased by 36.14%

from 290.52M

Revenue Next Year

560.82M

Increased by 41.80%

from 395.50M

EPS This Year

6.25

Increased by 108.25%

from 3.00

EPS Next Year

8.02

Increased by 28.43%

from 6.25

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	50.70M	290.52M	395.50M	560.82M
Revenue Growth	-	-	-	-	473.02%	36.14%	41.80%
EPS	-1.71	-3.13	-5.49	0.39	3.00	6.25	8.02
EPS Growth	-	-	-	-	669.23%	108.25%	28.43%
Forward PE	-	-	-	-	-	37.48	29.18
No. Analysts	-	-	-	-	-	14	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	418.9M	669.2M
Avg	395.5M	560.8M
Low	373.9M	426.2M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	44.2%	69.2%
Avg	36.1%	41.8%
Low	28.7%	7.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	7.42	10.28
Avg	6.25	8.02
Low	4.80	4.42

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	147.5%	64.5%
Avg	108.3%	28.4%
Low	60.1%	-29.3%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.